2nd Next-Generation Conjugate Summit
21
Feb
-
23
Feb
2023
When
Boston
Massachusetts
USA
Where

With numerous next-generation conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

21 - 23 Feb 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Senior Vice President & Chief Medical Officer
Executive Director
Senior Director, Program Team Leader
Senior Manager, Technical Business Development
Vice President, Biology
Chief Scientific Officer
Founder and Chief Executive Officer
Senior Vice President, Chemistry & Manufacturing
Director, Chemistry and Early Discovery
Principal Scientist
Vice President / Head of Biology

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Theratechnologies Inc.

Theratechnologies is a commercial-stage biopharmaceutical company. We currently market prescription products in the United States, Europe and Canada.

Abzena

Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US.

NJ Bio

NJ Biopharmaceuticals LLC (d/b/a NJ Bio) is a CRO that provides integrated chemistry and biology services to clients from the biotech and pharma sectors.

BSP Pharmaceuticals S.p.A.

BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.

PROVEO

Formed in 2015, PROVEO is now a Division of Cerbios- Pharma SA focused on complete supply chain solution for Antibody Drug Conjugates (ADCs).

Cerbios-Pharma SA

With more than 45 years’ experience in the pharmaceutical industry, Swiss-based CERBIOS is specialized in the manufacturing of Generic APIs&HPAPIs alongside with finished formulations based on its own probiotic strain and exclusive CDMO services for

Goodwin Biotechnology, Inc.

Goodwin Biotechnology, Inc.

Organizer

Get emails from us

Thank you
Oops! Something went wrong